FR_End-2023G-SIB | SOCIETE GENERALE |
End-2023G-SIB Assessment Exercise | v5.3.5 | ||||||
General Bank Data | |||||||
Section 1 - General Information | GSIB | Response | |||||
a. General information provided by the relevant supervisory authority: | |||||||
(1) | Country code | 1001 | FR | 1.a.(1) | |||
(2) | Bank name | 1002 | SocieteGenerale | 1.a.(2) | |||
(3) | Reporting date (yyyy-mm-dd) | 1003 | 2023-12-31 | 1.a.(3) | |||
(4) | Reporting currency | 1004 | EUR | 1.a.(4) | |||
(5) | Euro conversion rate | 1005 | 1 | 1.a.(5) | |||
(6) | Submission date (yyyy-mm-dd) | 1006 | 2024-03-27 | 1.a.(6) | |||
b. General Information provided by the reporting institution: | |||||||
(1) | Reporting unit | 1007 | 1 | 1.b.(1) | |||
(2) | Accounting standard | 1008 | IFRS | 1.b.(2) | |||
(3) | Date of public disclosure (yyyy-mm-dd) | 1009 | 2024-04-30 | 1.b.(3) | |||
(4) | Language of public disclosure | 1010 | English | 1.b.(4) | |||
(5) | Web address of public disclosure | 1011 | https://www.societegenerale.com/fr | 1.b.(5) | |||
(6) | LEI code | 2015 | O2RNE8IBXP4R0TD8PU41 | 1.b.(6) | |||
Size Indicator | |||||||
Section 2 - Total Exposures | GSIB | Amount in single EUR | |||||
a. Derivatives | |||||||
(1) | Counterparty exposure of derivatives contracts | 1012 | 19 814 776 272 | 2.a.(1) | |||
(2) | Effective notional amount of written credit derivatives | 1201 | 2 086 140 916 | 2.a.(2) | |||
(3) | Potential future exposure of derivative contracts | 1018 | 71 944 931 202 | 2.a.(3) | |||
b. Securities financing transactions (SFTs) | |||||||
(1) | Adjusted gross value of SFTs | 1013 | 218 706 365 513 | 2.b.(1) | |||
(2) | Counterparty exposure of SFTs | 1014 | 13 888 319 135 | 2.b.(2) | |||
c. Other assets | 1015 | 982 741 794 637 | 2.c. | ||||
d. Gross notional amount of off-balance sheet items | |||||||
(1) | Items subject to a 10% credit conversion factor (CCF) | 1019 | 13 246 329 614 | 2.d.(1) | |||
(2) | Items subject to a 20% CCF | 1022 | 79 858 847 103 | 2.d.(2) | |||
(3) | Items subject to a 40% CCF | 2300 | 0 | 2.d.(3) | |||
(4) | Items subject to a 50% CCF | 1023 | 160 967 728 566 | 2.d.(4) | |||
(5) | Items subject to a 100% CCF | 1024 | 25 906 096 907 | 2.d.(5) | |||
e. Regulatory adjustments | 1031 | 10 853 607 666 | 2.e. | ||||
f. Total exposures prior to regulatory adjustments (sum of items 2.a.(1) through 2.c, 0.1 times 2.d.(1), 0.2 times | |||||||
2.d.(2), 0.4 times 2.d.(3), 0.5 times 2.d.(4), and 2.d.(5)) | 1103 | 1 432 868 691 246 | 2.f. | ||||
g. Exposures of insurance subsidiaries not included in 2.f net of intragroup: | |||||||
(1) | On-balance sheet and off-balance sheet assets of insurance subsidiaries | 1701 | 171 417 871 318 | 2.g.(1) | |||
(2) | Potential future exposure of derivatives contracts of insurance subsidiaries | 1205 | 144 645 000 | 2.g.(2) | |||
(3) | Investment value in consolidated entities | 1208 | 5 094 316 649 | 2.g.(3) | |||
h. Intragroup exposures included in 2.f to insurance subsidiaries reported in 2.g | 2101 | 12 332 168 610 | 2.h. | ||||
i. Total exposures indicator, including insurance subsidiaries (sum of items 2.f, 2.g.(1) through 2.g.(2) minus | |||||||
2.g.(3) through 2.h) | 1117 | 1 587 004 722 305 | 2.i. | ||||
Page 1/3
FR_End-2023G-SIB | SOCIETE GENERALE |
Interconnectedness Indicators
Section 3 - Intra-Financial System Assets | GSIB | Amount in single EUR | |||
a. Funds deposited with or lent to other financial institutions | 1216 | 87 622 561 310 | 3.a. | ||
(1) | Certificates of deposit | 2102 | 0 | 3.a.(1) | |
b. Unused portion of committed lines extended to other financial institutions | 1217 | 47 148 819 324 | 3.b. | ||
c. Holdings of securities issued by other financial institutions | |||||
(1) | Secured debt securities | 2103 | 36 552 902 740 | 3.c.(1) | |
(2) | Senior unsecured debt securities | 2104 | 0 | 3.c.(2) | |
(3) | Subordinated debt securities | 2105 | 0 | 3.c.(3) | |
(4) | Commercial paper | 2106 | 0 | 3.c.(4) | |
(5) | Equity securities | 2107 | 63 308 405 204 | 3.c.(5) | |
(6) | Offsetting short positions in relation to the specific equity securities included in item 3.c.(5) | 2108 | 8 101 422 704 | 3.c.(6) | |
d. Net positive current exposure of SFTs with other financial institutions | 1219 | 13 003 381 793 | 3.d. | ||
e. OTC derivatives with other financial institutions that have a net positive fair value | |||||
(1) | Net positive fair value | 2109 | 4 899 773 317 | 3.e.(1) | |
(2) | Potential future exposure | 2110 | 14 666 927 304 | 3.e.(2) | |
f. Intra-financial system assets indicator, including insurance subsidiaries (sum of items 3.a, 3.b through 3.c.(5), | |||||
3.d, 3.e.(1), and 3.e.(2), minus 3.c.(6)) | 1215 | 259 101 348 288 | 3.f. | ||
Section 4 - Intra-Financial System Liabilities | GSIB | Amount in single EUR | |||
a. Funds deposited by or borrowed from other financial institutions | |||||
(1) | Deposits due to depository institutions | 2111 | 59 665 788 709 | 4.a.(1) | |
(2) | Deposits due to non-depository financial institutions | 2112 | 82 437 333 045 | 4.a.(2) | |
(3) | Loans obtained from other financial institutions | 2113 | 0 | 4.a.(3) | |
b. Unused portion of committed lines obtained from other financial institutions | 1223 | 39 421 561 717 | 4.b. | ||
c. Net negative current exposure of SFTs with other financial institutions | 1224 | 82 157 592 741 | 4.c. | ||
d. OTC derivatives with other financial institutions that have a net negative fair value | |||||
(1) | Net negative fair value | 2114 | 11 275 626 432 | 4.d.(1) | |
(2) | Potential future exposure | 2115 | 21 716 788 721 | 4.d.(2) | |
e. Intra-financial system liabilities indicator, including insurance subsidiaries (sum of items 4.a.(1) through 4.d.(2)) | 1221 | 296 674 691 365 | 4.e. | ||
Section 5 - Securities Outstanding | GSIB | Amount in single EUR | |||
a. Secured debt securities | 2116 | 50 601 972 379 | 5.a. | ||
b. Senior unsecured debt securities | 2117 | 142 654 911 473 | 5.b. | ||
c. Subordinated debt securities | 2118 | 24 651 103 218 | 5.c. | ||
d. Commercial paper | 2119 | 22 324 484 737 | 5.d. | ||
e. Certificates of deposit | 2120 | 17 965 515 263 | 5.e. | ||
f. Common equity | 2121 | 19 295 608 006 | 5.f. | ||
g. Preferred shares and any other forms of subordinated funding not captured in item 5.c. | 2122 | 0 | 5.g. | ||
h. Securities outstanding indicator, including the securities issued by insurance subsidiaries (sum of items 5.a throu | 1226 | 277 493 595 076 | 5.h. | ||
Page 2/3
FR_End-2023G-SIBSOCIETE GENERALE
Substitutability/Financial Institution Infrastructure Indicators
Section 6 - Payments made in the reporting year (excluding intragroup payments) | GSIB | Amount in single EUR | |||||
a. Australian dollars (AUD) | 1061 | 273 818 066 233 | 6.a. | ||||
b. Canadian dollars (CAD) | 1063 | 321 468 053 993 | 6.b. | ||||
c. Swiss francs (CHF) | 1064 | 425 052 774 527 | 6.c. | ||||
d. Chinese yuan (CNY) | 1065 | 774 751 248 554 | 6.d. | ||||
e. Euros (EUR) | 1066 | 17 988 689 728 281 | 6.e. | ||||
f. British pounds (GBP) | 1067 | 1 477 291 405 976 | 6.f. | ||||
g. Hong Kong dollars (HKD) | 1068 | 408 084 168 465 | 6.g. | ||||
h. Indian rupee (INR) | 1069 | 56 824 094 654 | 6.h. | ||||
i. Japanese yen (JPY) | 1070 | 2 886 125 873 291 | 6.i. | ||||
j. Swedish krona (SEK) | 1071 | 96 916 874 693 | 6.j. | ||||
k. Singapore dollar (SGD) | 2133 | 2 900 257 642 | 6.k. | ||||
l. United States dollars (USD) | 1072 | 11 992 047 091 821 | 6.l. | ||||
m. Payments activity indicator (sum of items 6.a through 6.l) | 1073 | 36 703 969 638 131 | 6.m. | ||||
Section 7 - Assets Under Custody | GSIB | Amount in single EUR | |||||
a. Assets under custody indicator | 1074 | 2 924 680 759 203 | 7.a. | ||||
Section 8 - Underwritten Transactions in Debt and Equity Markets | GSIB | Amount in single EUR | |||||
a. Equity underwriting activity | 1075 | 2 160 079 378 | 8.a. | ||||
b. Debt underwriting activity | 1076 | 110 001 000 000 | 8.b. | ||||
c. Underwriting activity indicator (sum of items 8.a and 8.b) | 1077 | 112 161 079 378 | 8.c. | ||||
Section 9 - Trading Volume | GSIB | Amount in single EUR | |||||
a. Trading volume of securities issued by other public sector entities, excluding intragroup transactions | 2123 | 52 778 572 537 | 9.a. | ||||
b. Trading volume of other fixed income securities, excluding | intragroup transactions | 2124 | 784 826 153 048 | 9.b. | |||
c. Trading volume fixed income sub-indicator (sum of items 9.a and 9.b) | 2125 | 837 604 725 585 | 9.c. | ||||
d. Trading volume of listed equities, excluding intragroup transactions | 2126 | 3 130 540 276 361 | 9.d. | ||||
e. Trading volume of all other securities, excluding intragroup transactions | 2127 | 377 732 132 256 | 9.e. | ||||
f. Trading volume equities and other securities sub-indicator (sum of items 9.d and 9.e) | 2128 | 3 508 272 408 617 | 9.f. | ||||
Complexity indicators | |||||||
Section 10 - Notional Amount of Over-the-Counter (OTC) Derivatives | GSIB | Amount in single EUR | |||||
a. OTC derivatives cleared through a central counterparty | 2129 | 7 551 939 411 614 | 10.a. | ||||
b. OTC derivatives settled bilaterally | 1905 | 8 556 821 102 292 | 10.b. | ||||
c. Notional amount of over-the-counter (OTC) derivatives indicator, including insurance subsidiaries (sum of | |||||||
items 10.a and 10.b) | 1227 | 16 108 760 513 905 | 10.c. | ||||
Section 11 - Trading and Available-for-Sale Securities | GSIB | Amount in single EUR | |||||
a. Held-for-trading securities (HFT) | 1081 | 114 334 105 013 | 11.a. | ||||
b. Available-for-sale securities (AFS) | 1082 | 37 993 398 663 | 11.b. | ||||
c. Trading and AFS securities that meet the definition of Level 1 assets | 1083 | 37 734 491 361 | 11.c. | ||||
d. Trading and AFS securities that meet the definition of Level 2 assets, with haircuts | 1084 | 12 348 963 888 | 11.d. | ||||
e. Trading and AFS securities indicator (sum of items 11.a and 11.b, minus the sum of 11.c and 11.d) | 1085 | 102 244 048 427 | 11.e. | ||||
Section 12 - Level 3 Assets | GSIB | Amount in single EUR | |||||
a. Level 3 assets indicator, including insurance subsidiaries | 1229 | 27 863 000 000 | 12.a | ||||
Cross-Jurisdictional Activity Indicators | |||||||
Section 13 - Cross-Jurisdictional Claims | GSIB | Amount in single EUR | |||||
a. Total foreign claims on an ultimate risk basis | 1087 | 554 950 470 051 | 13.a. | ||||
b. Foreign derivative claims on an ultimate risk basis | 1146 | 18 978 780 233 | 13.b. | ||||
c. Cross-jurisdictional claims indicator (sum of items 13.a and 13.b) | 2130 | 573 929 250 284 | 13.c. | ||||
Section 14 - Cross-Jurisdictional Liabilities | GSIB | Amount in single EUR | |||||
a. Foreign liabilities on an immediate risk basis, excluding derivatives and including local liabilities in local currency | 2131 | 480 069 566 453 | 14.a. | ||||
b. Foreign derivative liabilities on an immediate risk basis | 1149 | 76 478 552 506 | 14.b. | ||||
c. Cross-jurisdictional liabilities indicator (sum of items 14.a and 14.b) | 1148 | 556 548 118 959 | 14.c. |
Page 3/3
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Société Générale SA published this content on 30 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 April 2024 06:41:44 UTC.